18,587 articles
Philip Feigelson
Philip Feigelson (1925–2001) was an American biochemist at Columbia University's College of Physicians and Surgeons who studied hormonal control of gene expression in rat liver.
Philip Felig
Philip Felig was an American endocrinologist who spent fourteen years as a Yale professor of medicine, established the glucose-alanine cycle, led the Sandoz Research Institute, and died in 2020.
Philip Goulder
Philip J. R. Goulder is a British physician-scientist and Professor of Immunology at Oxford known for defining CTL escape in HIV and leading pediatric HIV cure research.
Philip Greenland
Philip Greenland is an American cardiologist and epidemiologist, the Harry W. Dingman Professor of Cardiology at Northwestern University, known for coronary artery calcium scoring for heart disease risk prediction.
Philip H. Henneman
Philip H. Henneman was an American endocrinologist who researched kidney stones and metabolic bone disease, best known for establishing urinary hydroxyproline as a marker of bone collagen turnover in 1963.
Philip Handler
Philip Handler (1917–1981) was an American biochemist who spent thirty years building Duke University's biochemistry department, then served twelve years as President of the National Academy of Sciences.
Philip Haydon
Philip G. Haydon is a neuroscientist and Professor of Neuroscience Emeritus at Tufts University School of Medicine, known for discovering that astrocytes signal to neurons and for co-founding GliaCure.
Philip Hieter
Philip Hieter is an American-trained Canadian geneticist, professor of medical genetics at the University of British Columbia, known for yeast chromosome stability genes and synthetic-lethality approaches to cancer drug targets.
Philip J. Barter
Philip J. Barter was an Australian cardiovascular researcher specializing in HDL cholesterol and CETP, who chaired the ILLUMINATE trial of torcetrapib and won the Anitschkow Prize in 2011.
Philip J. Cowen
Philip J. Cowen is a psychiatrist and Professor of Psychopharmacology at the University of Oxford whose 1997 Lancet tryptophan-depletion study showed how serotonin relates to depressive relapse.
Philip J. Darlington
Philip J. Darlington (1904–1983) was an American entomologist and biogeographer at Harvard, curator of insects at the Museum of Comparative Zoology, known for his 1957 book Zoogeography.
Philip J. Farabaugh
Philip J. Farabaugh is an American molecular biologist at the University of Maryland, Baltimore County whose laboratory discovered programmed +1 frameshifting in yeast retrotransposons and studies translational misreading.
Philip J. Fialkow
Philip J. Fialkow (1934–1996) was an American physician-scientist and hematologist at the University of Washington who first showed that leukemia is a clonal stem-cell disease, and later served as the medical school's dean.
Philip J. Hogg
Philip J. Hogg (Philip Hogg) is an Australian biochemist at the Centenary Institute in Sydney who showed disulphide bonds dynamically switch protein activity on and off.
Philip J. Landrigan
Philip J. Landrigan is an American pediatrician and epidemiologist whose El Paso lead studies helped remove lead from gasoline and shaped children's environmental health policy.
Philip J. Santangelo
Philip J. Santangelo is a biomedical engineer and professor at Georgia Tech and Emory known for single-molecule RNA imaging probes and inhalable mRNA therapeutics and vaccines.
Philip J. Snodgrass
Philip J. Snodgrass is an American physician and Professor Emeritus of Medicine at Indiana University, known for his 1974 and 1976 reports on urea-cycle enzyme deficiencies, including Reye's syndrome.
Philip Jones (cancer researcher)
Philip H. Jones is a British clinician-scientist who studies the earliest stages of cancer, and a Cambridge professor and Sanger Institute group leader elected a Fellow of the Royal Society in 2023.
Philip Kranzusch
Philip Kranzusch is a structural biologist and microbiologist who leads cancer immunology and virology research at Dana-Farber and Harvard, showing human innate immunity evolved from bacterial antiphage defense.
Philip L. De Jager
Philip L. De Jager is a neurologist and neuroimmunologist-geneticist, the Weil-Granat Professor of Neurology at Columbia University, known for large-scale genetic and single-cell studies of multiple sclerosis and Alzheimer's disease.
Philip L. Felgner
Philip L. Felgner is an American biochemist who pioneered lipofection, delivering DNA and RNA into cells with synthetic cationic lipids, and won the 2022 Robert Koch Prize.
Philip Leder
Philip Leder (1934–2020) was an American molecular geneticist who helped decipher the genetic code at NIH, then founded Harvard Medical School's genetics department and created the OncoMouse.
Philip Levine (physician)
Philip Levine (1900–1987) was a Russian-born American physician, bacteriologist, and serologist who established the Rh factor as the cause of hemolytic disease of the newborn.
Philip McGuire
Philip McGuire is a British psychiatrist and Professor of Psychiatry at the University of Oxford, known for brain imaging and clinical trial research on schizophrenia and psychosis.
Philip McMaster
Philip Duryee McMaster (1891–1973) was an American pathologist and microbiologist at the Rockefeller Institute in New York whose work on blood clotting and gallbladder function entered clinical diagnostic practice.
Philip Mease
Philip J. Mease is an American rheumatologist, clinical professor at the University of Washington and director of rheumatology research at Swedish Medical Center in Seattle.
Philip N. Hawkins
Philip N. Hawkins, also known as Philip Hawkins, is a British rheumatologist at University College London who developed SAP scintigraphy for imaging amyloid deposits and founded the NHS National Amyloidosis Centre in 1999.
Philip N. Newsome
Philip N. Newsome is a British hepatologist known for leading trials of semaglutide and liraglutide in fatty liver disease and co-leading the renaming of NAFLD as MASLD.
Philip N. Tsichlis
Philip Tsichlis is a molecular oncologist whose laboratory discovered the AKT oncogene and cloned the Tpl2 kinase, holding faculty posts at Fox Chase, Thomas Jefferson, and Tufts.
Philip Needleman
Philip Needleman (1939–2024) was an American pharmacologist who chaired pharmacology at Washington University, discovered COX-2, and led Monsanto and Pharmacia research that produced the arthritis drug Celebrex.